Confidently Grow Your Mass Tort / Class Action Firm.

Mass tort and class action litigation demands massive upfront capital, marketing campaigns, intake operations, medical record reviews, expert witnesses, and years of case development before a single dollar settles. Tortlink connects mass tort firms with capital providers who understand docket-level financing and the long timelines these cases require.

Mass Tort / Class Action Funding
How mass tort / class action firms put capital to work
DOCKET-LEVEL
Common Use Cases
Mass marketing & intake campaigns
Medical record review at scale
Expert witness retention
MDL common benefit funding
Co-counsel cost sharing
Potential Benefits

How Litigation Funding Helps Mass Tort / Class Action Firms

Risk Mitigation

Secure non-recourse lending structures where you only repay if cases succeed. Protect your firm's personal assets while pursuing high-value, complex litigation across thousands of claimants.

Scalability

Fund aggressive marketing campaigns and intake operations to grow your mass tort docket. More claimants means more leverage in MDL negotiations and larger aggregate settlements.

Resource Allocation

Invest in expert witnesses, medical professionals, research teams, and technology infrastructure without draining your operating cash flow. Build the strongest case possible.

Competitive Edge

Access more capital than your competitors to pursue more clients, invest in better experts, and build larger dockets. In mass tort, scale wins.

Negotiation Power

A well-funded firm with a large docket commands respect at the negotiation table. Financial backing signals to defendants and their insurers that you can take cases to trial.

Focus on Strategy

Concentrate on developing case theory, managing bellwether trials, and coordinating with co-counsel, without worrying about whether you can cover next month's case costs.

Industry Deep Dive

Understanding Mass Tort / Class Action Litigation

Mass tort litigation involves claims brought by large groups of plaintiffs who have been harmed by the same product, drug, or corporate conduct. Unlike class actions where plaintiffs are treated as a single group, mass torts treat each plaintiff's case individually, meaning each claimant's injuries, damages, and circumstances are evaluated separately. This creates enormous complexity and cost, but also enormous potential value. Firms pursuing mass tort litigation must invest heavily in case acquisition (TV, digital marketing, intake centers), medical record review and analysis, expert retention, and often years of MDL participation before any individual case resolves. The firms that succeed in mass tort are the ones that can sustain this investment over time, which is exactly where litigation financing becomes critical.

Case Types Our Funders Finance

Common Mass Tort / Class Action Case Categories

01
Defective pharmaceuticals & medical devices
02
Toxic exposure & environmental contamination
03
Consumer product liability
04
Multi-district litigation (MDL) participation
05
Class action certification & settlement
06
Bellwether trial preparation
07
Mass arbitration proceedings
08
PFAS & forever chemicals litigation
09
Talcum powder & cosmetic product claims
10
Roundup / glyphosate herbicide litigation
11
Camp Lejeune water contamination
12
3M military earplug defect claims
Active Litigation Landscape

Specific Mass Torts We Finance

Tortlink provides capital solutions for firms pursuing cases across the most active mass tort categories in the market today.

01

PFAS / Forever Chemicals

Active MDL

PFAS (per- and polyfluoroalkyl substances) litigation involves claims against manufacturers of firefighting foam (AFFF), non-stick cookware, food packaging, and industrial chemicals that have contaminated drinking water systems nationwide. The PFAS MDL in South Carolina has consolidated thousands of cases, with municipal water systems, individuals, and businesses filing claims for contamination, personal injury, and property damage. Firms building PFAS dockets need capital for water testing, medical screening, environmental expert witnesses, and sustained marketing campaigns targeting affected communities.

02

Talcum Powder / Ovarian Cancer

Active MDL

Talcum powder litigation alleges that major consumer products companies knew their talc-based products were contaminated with asbestos and failed to warn consumers. Thousands of women have filed claims linking long-term talcum powder use to ovarian cancer and mesothelioma. This litigation has produced some of the largest mass tort verdicts in history. Firms need capital for medical causation experts, epidemiologists, product testing, and sustained case acquisition as new plaintiffs continue to come forward.

03

Camp Lejeune Water Contamination

Active, PACT Act

The Camp Lejeune Justice Act of 2022 opened the door for military service members, families, and civilian workers exposed to contaminated water at Camp Lejeune between 1953 and 1987 to file claims against the federal government. The contamination involved toxic chemicals including TCE, PCE, benzene, and vinyl chloride linked to cancers, birth defects, and other serious illnesses. This is one of the largest government liability cases in history, and firms need capital for military service record acquisition, medical record review, and large-scale intake operations.

04

Roundup / Glyphosate Herbicide

Active, Ongoing Settlements

Roundup litigation alleges that glyphosate-based herbicides cause non-Hodgkin lymphoma and other cancers. Despite multi-billion dollar settlement programs, new claims continue to be filed as additional plaintiffs are diagnosed. Firms entering or expanding in this space need capital for medical record review, agricultural use documentation, and expert oncology testimony. The science continues to evolve with new studies on glyphosate exposure, keeping this litigation active and investable.

05

Hair Relaxer / Uterine Cancer

Active MDL

Hair relaxer litigation involves claims that chemical hair straightening products, disproportionately marketed to and used by Black women, contain endocrine-disrupting chemicals linked to uterine cancer, ovarian cancer, and endometriosis. The MDL is consolidated in the Northern District of Illinois. This is a growing litigation area with significant case acquisition opportunities and strong causation science emerging from NIH-funded studies.

06

Acetaminophen / Tylenol ADHD & Autism

Active MDL

This emerging litigation alleges that prenatal exposure to acetaminophen (Tylenol) is linked to increased risk of ADHD and autism spectrum disorder in children. The MDL is consolidated in the Southern District of New York. While the science is still developing and early bellwether rulings have been mixed, firms continue to build dockets in anticipation of strengthening causation evidence. Capital is needed for medical expert retention, epidemiological research review, and plaintiff identification.

07

Firefighting Foam (AFFF) Personal Injury

Active MDL

Beyond the broader PFAS environmental litigation, AFFF personal injury claims focus specifically on firefighters and military personnel who were directly exposed to aqueous film-forming foam during training and emergency response. These individuals face elevated cancer risks including testicular, kidney, and thyroid cancers. Firms need capital for occupational exposure documentation, medical screening programs, and coordination with the broader PFAS MDL proceedings.

08

NEC / Baby Formula

Active MDL

Necrotizing enterocolitis (NEC) litigation involves claims that cow's milk-based infant formula products, particularly those sold to neonatal intensive care units for premature infants, cause NEC, a devastating intestinal disease. Major formula manufacturers are defendants in an MDL consolidated in the Northern District of Illinois. Firms need capital for neonatal medical experts, NICU record acquisition, and targeted case identification among families of premature infants.

Capital Challenges

Financial Challenges Mass Tort / Class Action Firms Face

Massive Upfront Marketing Spend

Building a mass tort docket requires significant investment in television, digital advertising, and intake operations, often millions of dollars, before you see any return. Capital facilities bridge this gap.

Extended Case Timelines

Mass tort cases routinely take 3–7+ years from initial filing to resolution. During that time, your firm needs to cover case costs, payroll, and operations without settlement revenue.

MDL Coordination Costs

Active participation in MDL proceedings requires funding common benefit work, discovery contributions, and bellwether trial preparation, all of which are expensive and resource-intensive.

Medical Record Review at Scale

Processing thousands of claimant medical records requires dedicated intake teams, medical reviewers, and case management technology. These costs scale linearly with docket size.

Why Tortlink

Why Tortlink for Mass Tort / Class Action?

Tortlink's network includes capital providers who specialize in mass tort financing, lenders who understand docket-level valuations, MDL timelines, and the economics of large-scale plaintiff acquisition. We've structured deals for firms with dockets ranging from 200 to 20,000+ claimants across pharmaceutical, environmental, and product liability categories. Our memo team generates investment memos that speak directly to what mass tort lenders want to see: docket composition by case stage, per-case value estimates, expected resolution timelines, and marketing ROI analysis.

Start Your Funding Request